AR022099A1 - Una composicion oftalmica de liberacion sostenida y un metodo para terapia ocular - Google Patents
Una composicion oftalmica de liberacion sostenida y un metodo para terapia ocularInfo
- Publication number
- AR022099A1 AR022099A1 ARP990104845A ARP990104845A AR022099A1 AR 022099 A1 AR022099 A1 AR 022099A1 AR P990104845 A ARP990104845 A AR P990104845A AR P990104845 A ARP990104845 A AR P990104845A AR 022099 A1 AR022099 A1 AR 022099A1
- Authority
- AR
- Argentina
- Prior art keywords
- ophthalmic composition
- eye therapy
- sustained liberation
- liberation
- sustained
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Una composicion oftálmica que comprende:al menos un ingrediente activo básico; un polímero polianionico; una resina de intercambio ionico; y un agente paraajustar pH, estando dicho agente presente en una cantidad suficiente para ajustar el pH de lac omposicion a un valor comprendido entre aproximadamente 3,5 yaproximadamente 9,5. Se provee también un método de tratamiento ocular que emplea dicha composicion.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10195998P | 1998-09-25 | 1998-09-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR022099A1 true AR022099A1 (es) | 2002-09-04 |
Family
ID=22287389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990104845A AR022099A1 (es) | 1998-09-25 | 1999-09-24 | Una composicion oftalmica de liberacion sostenida y un metodo para terapia ocular |
Country Status (8)
Country | Link |
---|---|
US (1) | US6486208B1 (es) |
EP (1) | EP1115406A4 (es) |
JP (1) | JP2003517441A (es) |
AR (1) | AR022099A1 (es) |
AU (1) | AU761785B2 (es) |
BR (1) | BR9913955A (es) |
CA (1) | CA2345466C (es) |
WO (1) | WO2000018316A2 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020198174A1 (en) * | 2001-05-07 | 2002-12-26 | Allergan Sales, Inc. | Disinfecting and solubilizing steroid compositions |
US7081482B2 (en) * | 1999-11-30 | 2006-07-25 | Alcon, Inc. | Use of β-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina |
CA2428799A1 (en) * | 2000-11-16 | 2002-05-23 | Alcon Manufacturing, Ltd. | Combination therapy for lowering and controlling intraocular pressure |
US6752786B2 (en) | 2001-05-31 | 2004-06-22 | Radiant Medical, Inc. | Moving heat exchange catheter system |
FR2837710B1 (fr) * | 2002-03-26 | 2005-07-08 | Innovations Pharma Ag | Composition topique a base de resines echangeuses d'ions, notamment pour le traitement des erythemes |
US8580851B2 (en) | 2002-08-21 | 2013-11-12 | Sucampo Ag | Ophthalmic solution |
EP2404606A1 (en) * | 2003-08-21 | 2012-01-11 | Sucampo AG | Ophthalmic compositions comprising a prostaglandin and a viscosity agent |
ES2460967T3 (es) | 2005-08-02 | 2014-05-16 | Santen Pharmaceutical Co., Ltd. | Método para la prevención de la degradación de una sustancia térmicamente inestable |
WO2008035246A2 (en) | 2006-07-28 | 2008-03-27 | Novagali Pharma Sa | Compositions containing quaternary ammonium compounds |
DK1891939T3 (da) * | 2006-07-28 | 2013-10-07 | Novagali Pharma Sa | Sammensætninger indeholdende kvaternære ammoniumforbindelser |
JP5315252B2 (ja) * | 2006-12-22 | 2013-10-16 | シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ | 眼科用薬物の輸送に有用なゲル |
EP2127638A1 (en) | 2008-05-30 | 2009-12-02 | Santen Pharmaceutical Co., Ltd | Method and composition for treating ocular hypertension and glaucoma |
US20110293549A1 (en) | 2009-02-03 | 2011-12-01 | Athena Cosmetics, Inc. | Composition, method and kit for enhancing hair |
US10272040B2 (en) | 2010-08-12 | 2019-04-30 | Nanyang Technological University | Liposomal formulation for ocular drug delivery |
EP2452669A1 (en) * | 2010-10-29 | 2012-05-16 | Omnivision GmbH | Ophthalmic composition |
CN104208016A (zh) * | 2013-05-29 | 2014-12-17 | 天津金耀集团有限公司 | 含有曲伏前列腺素的眼部制剂 |
US9115109B2 (en) | 2013-08-15 | 2015-08-25 | Chirogate International Inc. | Processes and intermediates for the preparations of isomer free prostaglandins |
US9956195B2 (en) | 2014-01-07 | 2018-05-01 | Nanyang Technological University | Stable liposomal formulations for ocular drug delivery |
EP3954362A1 (en) * | 2014-07-28 | 2022-02-16 | Sun Pharma Advanced Research Company Ltd | Method of increasing bioavailability and/or prolonging ophthalmic action of a drug |
CN108066283B (zh) * | 2017-12-28 | 2020-03-24 | 兆科(广州)眼科药物有限公司 | 一种盐酸左倍他洛尔滴眼液的制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6056684B2 (ja) * | 1977-11-07 | 1985-12-11 | 東興薬品工業株式会社 | 点眼剤 |
US4911920A (en) * | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
US5093126A (en) * | 1987-09-26 | 1992-03-03 | Alcon Laboratories, Inc. | Glaucoma formulations comprising an anionic, polysulfonic acid polymer having mucomimetic properties and a polystyrene sulfonic polymer |
US5182102A (en) * | 1991-07-12 | 1993-01-26 | Alcon Laboratories, Inc. | Anti-glaucoma compositions |
US5662919A (en) * | 1994-11-21 | 1997-09-02 | Alcon Laboratories, Inc. | Sulfated polyvinyl alcohol polymers to stabilize pharmaceutical drug compounds |
-
1999
- 1999-09-22 BR BR9913955-3A patent/BR9913955A/pt not_active Application Discontinuation
- 1999-09-22 WO PCT/US1999/021957 patent/WO2000018316A2/en active IP Right Grant
- 1999-09-22 JP JP2000571839A patent/JP2003517441A/ja active Pending
- 1999-09-22 US US09/787,203 patent/US6486208B1/en not_active Expired - Fee Related
- 1999-09-22 EP EP99969661A patent/EP1115406A4/en not_active Withdrawn
- 1999-09-22 AU AU60571/99A patent/AU761785B2/en not_active Ceased
- 1999-09-22 CA CA002345466A patent/CA2345466C/en not_active Expired - Fee Related
- 1999-09-24 AR ARP990104845A patent/AR022099A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2345466A1 (en) | 2000-04-06 |
EP1115406A2 (en) | 2001-07-18 |
CA2345466C (en) | 2007-01-23 |
AU6057199A (en) | 2000-04-17 |
JP2003517441A (ja) | 2003-05-27 |
AU761785B2 (en) | 2003-06-12 |
EP1115406A4 (en) | 2003-03-05 |
WO2000018316A2 (en) | 2000-04-06 |
WO2000018316A3 (en) | 2000-11-16 |
BR9913955A (pt) | 2001-06-12 |
US6486208B1 (en) | 2002-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR022099A1 (es) | Una composicion oftalmica de liberacion sostenida y un metodo para terapia ocular | |
NZ597106A (en) | Ophthalmic compositions comprising carnitine and methods for treating eyes | |
BG100915A (en) | Ophthalmic composition with decreased viscosity | |
EP0868909A3 (en) | Ophthalmic carrier solution | |
DK0781547T3 (da) | Ophthalmisk formulering baseret på natriumhyaluronat til anvendelse i øjen-kirugi | |
CA2004468A1 (en) | Sustained release, comfort formulation for glaucoma therapy | |
CA2295061A1 (en) | Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin | |
CA2436269A1 (en) | Artificial tear composition containing a combination of three demulcents | |
AU2003298179A1 (en) | Lens care composition and method | |
PL328656A1 (en) | Ophthalmic composition of extended time of their retention in eyes | |
ES2179871T3 (es) | Composicion oftalmica que contiene un polimero hidrofilo sensible a los iones y una sal inorganica en una relacion que confiere baja viscosidad. | |
AU2001293851A1 (en) | Stabilized hydrogen peroxide solutions | |
NZ505742A (en) | Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses | |
MXPA02004701A (es) | Sales de hidroxieicosatetraenoato, composiciones y metodos de uso para tratar trastornos de resequedad en los ojos. | |
WO2000018387A3 (en) | Antibiotic compositions for treatment of the eye, ear and nose | |
BR0012696A (pt) | Composição oftálmica | |
BRPI0417175A (pt) | composições, método para produzir essas composições, solução que as compreende e métodos para utilizar as mesmas | |
CA2429982A1 (en) | Copper chelators for treating ocular inflammation | |
HK1045458A1 (en) | Ophthalmic histtamine compositions and uses thereof. | |
ITRM20010438A1 (it) | Preparato oftalmico a base di n-acetilcisteina per il trattamento della sindrome dell'occhio secco. | |
BR9811706A (pt) | Composições antimicrobianas brandas sem-remoção | |
HK1043739A1 (en) | Use of a pharmaceutical composition in the manufacture of a medicament for the treatment of pathological conditions of the eye caused by bacteria, viruses, fungi, yeasts and protozoa. | |
BR0209601A (pt) | Método para o tratamento da hipertensão ocular e do glaucoma | |
ES2080847T3 (es) | Utilizacion de naproxen como agente midriatico. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |